SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-018536
Filing Date
2021-05-06
Accepted
2021-05-06 21:21:43
Documents
2
Period of Report
2021-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4676
2 EX-24 DOCUMENT attachment1.htm EX-24 4551
  Complete submission text file 0000899243-21-018536.txt   10633
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TALARIS THERAPEUTICS, INC. 93 WORCESTER STREET, SUITE 120 WELLESLEY MA 02481
Business Address
Krieger Nancy (Reporting) CIK: 0001845672 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899944